Market revenue in 2024 | USD 128.8 million |
Market revenue in 2030 | USD 193.8 million |
Growth rate | 7% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 39.29% in 2024. Horizon Databook has segmented the Sweden cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of cardiovascular diseases, including arrhythmias and heart failure, in Sweden contributes to the demand for CRM devices. As the population ages and lifestyles change, there is a growing need for effective treatment options for these conditions, fueling market growth.
Sweden has a well-developed healthcare infrastructure with modern facilities and a high level of healthcare access. This infrastructure supports the adoption of advanced CRM devices and procedures. The Swedish government prioritizes healthcare spending, including investments in medical technology.
This funding supports R&D in CRM devices and facilitates their integration into clinical practice. For instance, in 2022, the Sweden government spent USD 10.89 billion on health, medical, and social care. Sweden consistently ranks among the countries with the highest healthcare expenditure per capita.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Sweden cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account